Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A pharmacokinetic study of desmopressin - Minirin vs Sandoz
2025-521256-29-00Phase 4Authorised
- Sponsor
- Central Denmark Region
- Start
- Aug 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of desmopressin in nocturnal enuresis (NE) (2 arms), sponsored by Central Denmark Region. Primary endpoint: Area under the curve (AUC). Planned start Aug 2025; status: authorised.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on 2025-521256-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521256-29-00.